THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. Quarterly Operating Income (Loss) in USD from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Therapeutic Solutions International, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q4 2010 to Q3 2024.
  • Therapeutic Solutions International, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$1.96M, a 328% decline year-over-year.
  • Therapeutic Solutions International, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$3.59M, a 50.5% decline year-over-year.
  • Therapeutic Solutions International, Inc. annual Operating Income (Loss) for 2023 was -$1.99M, a 39.4% increase from 2022.
  • Therapeutic Solutions International, Inc. annual Operating Income (Loss) for 2022 was -$3.28M, a 42.3% decline from 2021.
  • Therapeutic Solutions International, Inc. annual Operating Income (Loss) for 2021 was -$2.3M, a 24.6% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$3.59M -$1.96M -$1.5M -328% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-20
Q2 2024 -$2.09M -$404K +$138K +25.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-19
Q1 2024 -$2.23M -$673K -$243K -56.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-30
Q4 2023 -$1.99M -$557K +$401K +41.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-17
Q3 2023 -$2.39M -$457K +$262K +36.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-20
Q2 2023 -$2.65M -$543K +$533K +49.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-19
Q1 2023 -$3.18M -$430K +$96.8K +18.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-30
Q4 2022 -$3.28M -$958K -$40.1K -4.37% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-17
Q3 2022 -$3.24M -$719K -$17.2K -2.45% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$3.22M -$1.08M -$652K -154% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-21
Q1 2022 -$2.57M -$527K -$266K -102% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-16
Q4 2021 -$2.3M -$918K -$353K -62.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 -$1.95M -$702K -$212K -43.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-17
Q2 2021 -$1.74M -$423K +$249K +37% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-19
Q1 2021 -$1.99M -$261K -$139K -113% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-23
Q4 2020 -$1.85M -$565K -$37.7K -7.15% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$1.81M -$490K -$291K -146% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-22
Q2 2020 -$1.52M -$672K -$478K -246% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 -$1.04M -$122K $0 0% Jan 1, 2020 Mar 31, 2020 10-Q/A 2020-07-09
Q4 2019 -$1.04M -$527K -$154K -41.1% Oct 1, 2019 Dec 31, 2019 10-K/A 2021-04-12
Q3 2019 -$890K -$200K $0 0% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-20
Q2 2019 -$890K -$194K $0 0% Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-16
Q1 2019 -$890K -$122K +$310K +71.7% Jan 1, 2019 Mar 31, 2019 10-Q/A 2021-05-21
Q4 2018 -$1.2M -$373K -$160K -74.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-05-21
Q3 2018 -$1.04M -$200K +$57K +22.2% Jul 1, 2018 Sep 30, 2018 10-Q 2020-11-17
Q2 2018 -$1.1M -$194K +$40.1K +17.1% Apr 1, 2018 Jun 30, 2018 10-Q/A 2020-08-24
Q1 2018 -$1.14M -$433K -$253K -141% Jan 1, 2018 Mar 31, 2018 10-Q/A 2020-07-09
Q4 2017 -$884K -$214K +$147K +40.8% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-15
Q3 2017 -$1.03M -$257K -$77.2K -43% Jul 1, 2017 Sep 30, 2017 10-Q 2019-11-20
Q2 2017 -$954K -$234K +$42.3K +15.3% Apr 1, 2017 Jun 30, 2017 10-Q 2019-08-16
Q1 2017 -$996K -$180K +$45.9K +20.3% Jan 1, 2017 Mar 31, 2017 10-Q/A 2018-05-22
Q4 2016 -$1.04M -$361K -$155K -75.2% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-17
Q3 2016 -$887K -$179K -$887 -0.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-16
Q2 2016 -$886K -$277K -$165K -147% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$722K -$226K -$151K -201% Jan 1, 2016 Mar 31, 2016 10-Q 2017-07-05
Q4 2015 -$571K -$206K +$193K +48.4% Oct 1, 2015 Dec 31, 2015 10-K 2016-10-31
Q3 2015 -$764K -$178K -$243K -378% Jul 1, 2015 Sep 30, 2015 10-Q 2017-04-17
Q2 2015 -$521K -$112K -$239K -188% Apr 1, 2015 Jun 30, 2015 10-Q 2017-04-13
Q1 2015 -$282K -$74.9K +$45.4K +37.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-07-06
Q4 2014 -$327K -$398K +$750K +65.3% Oct 1, 2014 Dec 31, 2014 10-K 2016-10-31
Q3 2014 -$1.08M $64.2K -$96.6K -60.1% Jul 1, 2014 Sep 30, 2014 10-Q 2016-08-23
Q2 2014 -$981K $127K -$181K -58.6% Apr 1, 2014 Jun 30, 2014 10-Q 2016-05-09
Q1 2014 -$800K -$120K +$48.3K +28.7% Jan 1, 2014 Mar 31, 2014 10-Q 2016-07-06
Q4 2013 -$848K -$1.15M +$398K +25.7% Oct 1, 2013 Dec 31, 2013 10-K 2016-06-16
Q3 2013 -$1.25M $161K +$292K Jul 1, 2013 Sep 30, 2013 10-Q 2016-05-13
Q2 2013 -$1.54M $308K +$673K Apr 1, 2013 Jun 30, 2013 10-Q 2016-05-09
Q1 2013 -$2.21M -$169K +$221K +56.7% Jan 1, 2013 Mar 31, 2013 10-Q 2016-04-28
Q4 2012 -$2.43M -$1.55M -$1M -183% Oct 1, 2012 Dec 31, 2012 10-K 2016-04-22
Q3 2012 -$1.43M -$131K +$269K +67.2% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 -$1.7M -$365K -$280K -331% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-12
Q1 2012 -$1.42M -$389K -$380K -3871% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
Q4 2011 -$1.04M -$547K -$539K -7042% Oct 1, 2011 Dec 31, 2011 10-K 2013-03-29
Q3 2011 -$503K -$400K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-29
Q2 2011 -$84.7K Apr 1, 2011 Jun 30, 2011 10-Q 2012-11-21
Q1 2011 -$9.81K Jan 1, 2011 Mar 31, 2011 10-Q 2012-11-19
Q4 2010 -$7.66K Sep 21, 2010 Dec 31, 2010 10-K 2012-10-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.